Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor

Naoki Kubo, Taishi Harada, Satoshi Anai, Kohei Otsubo, Yasuto Yoneshima, Kayo Ijichi, Takaomi Koga, Koichi Takayama, Yoichi Nakanishi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A 26-year-old man with unresectable inflammatory myofibroblastic tumor (IMT) presented with multiple metastases in the thoracic vertebra and lymph nodes as detected by positron emission tomography (PET) received chemotherapy with carboplatin plus paclitaxel. After three cycles of chemotherapy, fluorine-18-fluorodeoxyglucose (FDG)-PET/CT revealed tumor regression and significant reduction of FDG uptake in all lesions. The patient received six cycles of chemotherapy without any severe adverse event, and there was no sign of disease progression for seven months. This regimen is well tolerated and may be considered the treatment of choice for unresectable IMT.

Original languageEnglish
Pages (from-to)2399-2401
Number of pages3
JournalInternal Medicine
Volume51
Issue number17
DOIs
Publication statusPublished - Oct 29 2012

Fingerprint

Carboplatin
Paclitaxel
Drug Therapy
Positron-Emission Tomography
Thoracic Vertebrae
Neoplasms
Fluorodeoxyglucose F18
Disease Progression
Therapeutics
Lymph Nodes
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor. / Kubo, Naoki; Harada, Taishi; Anai, Satoshi; Otsubo, Kohei; Yoneshima, Yasuto; Ijichi, Kayo; Koga, Takaomi; Takayama, Koichi; Nakanishi, Yoichi.

In: Internal Medicine, Vol. 51, No. 17, 29.10.2012, p. 2399-2401.

Research output: Contribution to journalArticle

Kubo, N, Harada, T, Anai, S, Otsubo, K, Yoneshima, Y, Ijichi, K, Koga, T, Takayama, K & Nakanishi, Y 2012, 'Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor', Internal Medicine, vol. 51, no. 17, pp. 2399-2401. https://doi.org/10.2169/internalmedicine.51.7599
Kubo, Naoki ; Harada, Taishi ; Anai, Satoshi ; Otsubo, Kohei ; Yoneshima, Yasuto ; Ijichi, Kayo ; Koga, Takaomi ; Takayama, Koichi ; Nakanishi, Yoichi. / Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor. In: Internal Medicine. 2012 ; Vol. 51, No. 17. pp. 2399-2401.
@article{876799e233f54a29b47a624590724efc,
title = "Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor",
abstract = "A 26-year-old man with unresectable inflammatory myofibroblastic tumor (IMT) presented with multiple metastases in the thoracic vertebra and lymph nodes as detected by positron emission tomography (PET) received chemotherapy with carboplatin plus paclitaxel. After three cycles of chemotherapy, fluorine-18-fluorodeoxyglucose (FDG)-PET/CT revealed tumor regression and significant reduction of FDG uptake in all lesions. The patient received six cycles of chemotherapy without any severe adverse event, and there was no sign of disease progression for seven months. This regimen is well tolerated and may be considered the treatment of choice for unresectable IMT.",
author = "Naoki Kubo and Taishi Harada and Satoshi Anai and Kohei Otsubo and Yasuto Yoneshima and Kayo Ijichi and Takaomi Koga and Koichi Takayama and Yoichi Nakanishi",
year = "2012",
month = "10",
day = "29",
doi = "10.2169/internalmedicine.51.7599",
language = "English",
volume = "51",
pages = "2399--2401",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "17",

}

TY - JOUR

T1 - Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor

AU - Kubo, Naoki

AU - Harada, Taishi

AU - Anai, Satoshi

AU - Otsubo, Kohei

AU - Yoneshima, Yasuto

AU - Ijichi, Kayo

AU - Koga, Takaomi

AU - Takayama, Koichi

AU - Nakanishi, Yoichi

PY - 2012/10/29

Y1 - 2012/10/29

N2 - A 26-year-old man with unresectable inflammatory myofibroblastic tumor (IMT) presented with multiple metastases in the thoracic vertebra and lymph nodes as detected by positron emission tomography (PET) received chemotherapy with carboplatin plus paclitaxel. After three cycles of chemotherapy, fluorine-18-fluorodeoxyglucose (FDG)-PET/CT revealed tumor regression and significant reduction of FDG uptake in all lesions. The patient received six cycles of chemotherapy without any severe adverse event, and there was no sign of disease progression for seven months. This regimen is well tolerated and may be considered the treatment of choice for unresectable IMT.

AB - A 26-year-old man with unresectable inflammatory myofibroblastic tumor (IMT) presented with multiple metastases in the thoracic vertebra and lymph nodes as detected by positron emission tomography (PET) received chemotherapy with carboplatin plus paclitaxel. After three cycles of chemotherapy, fluorine-18-fluorodeoxyglucose (FDG)-PET/CT revealed tumor regression and significant reduction of FDG uptake in all lesions. The patient received six cycles of chemotherapy without any severe adverse event, and there was no sign of disease progression for seven months. This regimen is well tolerated and may be considered the treatment of choice for unresectable IMT.

UR - http://www.scopus.com/inward/record.url?scp=84867801434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867801434&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.51.7599

DO - 10.2169/internalmedicine.51.7599

M3 - Article

C2 - 22975556

AN - SCOPUS:84867801434

VL - 51

SP - 2399

EP - 2401

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 17

ER -